UK becomes first country to approve Pfizer-BioNTech Covid-19 vaccine for use

▴ UK becomes first country to approve Pfizer-BioNTech Covid-19 vaccine for use
Britain became the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine today for use and said that it will be rolled out from early next week.

Britain became the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine today for use and said that it will be rolled out from early next week.

The British regulator Medicines and Healthcare products Regulatory Agency (MHRA) declared that the vaccine offers protection of up to 95 percent and is safe to be used for immunization against Covid-19.
 

According to a media statement, the Government has accepted the recommendation from the Independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve the Pfizer-BioNTechs COVID-19 vaccine for use. The vaccine will be made available across the UK from next week.

 
The American pharmaceutical giant Pfizer and its German partner BioNTech last month concluded a phase 3 study of their mRNA-based Covid-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
 
The UK has ordered up to 40 million doses of the vaccine, which is being organized to vaccinate 20 million people with two shots each. Immunization is expected to start within days and will be delivered to high-priority groups first.

The company expects to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021.

Tags : #Pfizer-BioNTech #Covid19Vaccine #MHRA #BioNTech #Pfizer #CovidVaccine #Vaccination #FightAgainstVirus #Britain #BritainGovernment #UnitedKingdom

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024